ISPOR Europe 2025 Home
  • About
    • Registration Information
    • News Center
  • Program
    • Program
    • Plenary Sessions
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsors
    • Media Partners
    • Exhibitor Directory
  • Photo Gallery
  • Award Winners
large-circle

ISPOR Europe 2025

9 - 12 November

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Europe 2026
  • Program
  • Paper
  • Optimizing the Use of Excess Hazard Models in Survival Analysis: Considering Disease Severity and Follow-up Maturity

    Sep 22, 2025, 16:24 PM
  • Survival Time-Adjusted Indirect Comparisons: A New Methodology for Comparing Between Phases of Treatment in Early Cancer

    Sep 22, 2025, 16:24 PM
  • Do Older People Always Prefer Avoiding Nursing Homes? Evidence in France From a Mixed-Methods Approach

    Sep 22, 2025, 16:24 PM
  • Assessment of Mortality and COPD Exacerbations in GOLD E COPD Patients in the Netherlands

    Sep 22, 2025, 16:24 PM
  • Comparative Performance of the EQ-5D-5L and PROMIS-10 in the Elderly: Data From the EQ-DAPHNIE Project in Five Countries

    Sep 22, 2025, 16:24 PM
  • Validation of Primary Care Resource Use and Costs in OMOP-Mapped vs. Source CPRD Aurum Data

    Sep 22, 2025, 16:24 PM
  • Optimal Hemoglobin Thresholds for ICU Transfusion: A Target Trial Emulation in a Large Electronic Medical Record-Based Real-World Database

    Sep 22, 2025, 16:24 PM
  • A Framework for Accelerating Clinical Development With Real-World External Control Arms (ECA) in Phase 2 Trials

    Sep 22, 2025, 16:24 PM
  • Real-World Evidence of Healthcare Resource Utilization in Cystic Fibrosis (CF) Patients Treated With Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in France Using Long-term Data From the SNDS Database Linked to the French CF Registry: Findings From...

    Sep 22, 2025, 16:24 PM
  • Treatment Burden and Quality of Life in Patients With nAMD and DME in Colombia: A Mixed Methods Study

    Sep 22, 2025, 16:24 PM
  • Implementation of Patient Experience Data in Clinical Trial Design: A Literature Review and Semi-Structured Interviews

    Sep 22, 2025, 16:24 PM
  • The Frequency of Mentions and Impact of Patient Input in HTA Decision Making in Cell and Gene Therapies Across the UK, Canada, and Australia

    Sep 22, 2025, 16:24 PM
  • Mixed-Method Exploration of Visual Analogue Scale (VAS) Variations to Measure Health, Social Care, and Carer-Related Quality of Life (QoL)

    Sep 22, 2025, 16:24 PM
  • Beyond PFS and OS: Recovering Pre- and Post-Progression Survival From Survival Curves

    Sep 22, 2025, 16:24 PM
  • The Longitudinal Population Health Impact of Opioid Settlement Funding: A Case Study from Pennsylvania in the United States

    Sep 22, 2025, 16:24 PM
  • Cost-Effectiveness Modeling of Test and Treat Strategies: A Diagnosis of Over-Complexity

    Sep 22, 2025, 16:24 PM
  • Impact of NHIS Reimbursement Caps on Epilepsy Care Equity and Outcomes in Ghana

    Sep 22, 2025, 16:24 PM
  • From Evidence to Equity: Leveraging Real-World HEOR Analysis to Transform Antidepressant Access Policy for Black Medicaid Beneficiaries in Maryland

    Sep 22, 2025, 16:24 PM
  • Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities From a Targeted Literature Review and Multi-Stakeholder Workshop

    Sep 22, 2025, 16:24 PM
  • Exploring Variability in EQ VAS Scores: A Systematic Review and Meta-Regression of Population Health Studies

    Sep 22, 2025, 16:24 PM
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group